GSK241220C44000
- 0.12
- 0.000.00%
GlaxoSmithKline Newsroom
Pfizer's Progress on C. Diff Vaccine and Pneumococcal Shot Wins Analyst Conviction
GSK COVID Antiviral Authorization for Sotrovimab Revoked by FDA
GlaxoSmithKline (GSK) Gets a Hold From Barclays
Express News | GSK Announced Headline Results From FIRST-ENGOT-OV44 Phase 3 Trial Of Zejula (Niraparib) And Jemperli (Dostarlimab) In First Line Advanced Ovarian Cancer, The Trial Met Its Primary Endpoint Of Progression-free Survival, The Key Secondary Endpoint Of...
GSK's Combination of Cancer Drugs Shows Positive Results in Late-Stage Trial
GSK's Ovarian Cancer Treatment Meets Primary Endpoint in Late-stage Study
Your Healthcare Costs Are Soaring! US Spending Reached $5 Trillion In 2023 With Major Increase in Obesity and Diabetes Drugs, Hospital Services
GlaxoSmithKline (GSK) Gets a Hold From Goldman Sachs
GSK (GSK.US) monoclonal antibody first-line therapy has received FDA breakthrough therapy designation for the treatment of rectal cancer.
The USA FDA has granted Breakthrough Therapy Designation (BTD) to its PD-1 inhibitor Jemperli (dostarlimab) for the treatment of locally advanced mismatch repair-deficient (dMMR)/high microsatellite instability (MSI-H) colorectal cancer.
Express News | CA Governor Newsom Proclaimed State Of Emergency To Further Enhance State's Preparedness And Accelerate The Bird Flu Cross-Agency Response Efforts
Express News | CDC Confirms First Severe Case Of H5N1 Bird Flu In U.S. On December 13; Patient Hospitalized With Severe Case Of Avian Influenza A Virus Infection In Louisiana
Promising Data for Treating Gastrointestinal Cancer Leading to Hopeful Advancements for Pancreatic & Anal Cancers
Cautious Outlook on GlaxoSmithKline: Sell Rating Due to Pipeline and Financial Challenges
European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading
GSK Gets CHMP Nod for Expanded Use of HIV Combo & Jemperli
Deutsche Bank Keeps Their Hold Rating on GlaxoSmithKline (GSK)
What's Going On Moderna Stock On Monday?
GSK's Jemperli Recommended for Expanded Approval in Endometrial Cancer, Receives Breakthrough Therapy Designation for Rectal Cancer
GSK Passes Three Significant Milestones With New Cancer Drug Given a Double Boost | LSE:GSK, NYSE:GSK
GSK's Rectal Cancer Treatment Receives Breakthrough Designation From US FDA